|
|
| MRD / Regn No. |
: THBC\23-24\05055 |
Date |
: 22/06/2026 |
| Patient Name |
: Bharti Gangar |
Age & Gender |
: 66 Yrs. / Female |
| Contact No. |
: 9768573659 |
UHID |
: |
| Ht / Wt / BMI |
: |
BP S / BP D |
: |
| Allergies |
: NONE |
Referred By |
: |
| |
|
| Problem
List |
: |
T2DM (06/Sep/2019) | DYSLIPIDEMIA (06/Sep/2021) | |
|
Subjective |
: |
T2DM SINCE 2019,DYSLIPIDEMIA SINCE 2021,NOT TRIED SGLT2 - TRIAL OF SAME FOR 2-3 WEEKS - IF TOLERATES WELL - TO CHECK SUGARS AND TRY TO REDUCE GLYCOMET TRIO 2
|
|
Objective |
: |
18-JUN-2026 REPORTS,FBS-145/ PPBS-173,ACR-6.03,HB-13.4/ HBA1C-7.2%,TC-161/ TG-139/ LDL-84/ HDL-49,ALT-24/ AST-28,CR-0.88,T3-0.77/ T4-7.6/ TSH-2.951,VITD-26.3,VITB12-225 |
|
Plan |
: |
STOPPING BIZFER XT - CHECK HB NEXT VISIT,SBP HIGHER SIDE - TO RECHECK AFTER STARTING DAPAVEL |
|
|
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
ROSUFIT 20 |
ORAL |
0-0-1 |
AD
|
4 MTHS |
|
|
2 |
SITAPRIDE M 50/500 MG |
ORAL |
1-0-1 |
BBF / BD
|
4 MTHS |
|
|
3 |
TABLET PIOGLITAZONE 7.5MG
PIOZ 7.5 MG |
ORAL |
0-0-1 |
BD
|
4 MTHS |
|
|
4 |
TABLET CHOLECALCIFEROL 60,000IU
DRISE 60K |
ORAL |
ONCE A MTH |
ANYTIME OF DAY
|
4 MTHS |
|
|
5 |
TABLET GLIMEPIRIDE (2MG)+ METFORMIN(500)+ VOGLIBOSE(0.2)
GLYCOMET TRIO 2 |
ORAL |
1-0-1 |
BBF/BD
|
4 MTHS |
|
|
6 |
TAB DAPAVEL 10 MG |
ORAL |
1-0-0 |
BBF
|
4 MTHS |
|
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: IF LOW SUGARS (<70 MG/DL),TAKE 1 TBSP(15GMS) GLUCOSE POWDER. CHECK AGAIN AFTER 15 MINS IF >100 CAN GIVE A PROTEIN MEAL. |
| Next Visit |
: 24/Jun/2026 |
| Tests Suggested For Next Visit |
: FBS / PPBS > 3 WEEKS - IF SUGARS LOWER - REDUCE GLYCOMET TRYO 2,NEXT VISIT - HBA1C / FBS / PPBS / CBC / RFT / LFT / LIPID PROFILE / URINE FOR ALBUMINLCREAT RATIO |
| |
|
| |
|
Dr Tejal Lathia
M.D, D.M (Endocrinology)
Maharashtra /
2003/05/2166
This is a Computer generated Prescription |
Powered By:  |
|